CD274 and glioma: This study established a glioma risk score model based on 6 PD-L1- related lncRNAs from an immunological perspective, which can effectively reflect the clinical characteristics, prognosis, pathological features, immunoinflammatory microenvironment and immunotherapy reactivity of glioma patients.